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CLINICAL OUTCOME
Four days after the initial pericardiocentesis, the
patient underwent localized pericardectomy due
to re-accumulation of pericardial ﬂuid. (Figure 1)
Full-thickness pericardial biopsy was also per-
formed. Negative serology included: human
immunodeﬁciency virus types I and II, human
T-cell leukemia virus types I and II, cytomegalo-
virus immunoglobulin M (CMV IgM), Venereal
Disease Research Laboratory (VDRL), antinuclear
antibody, native DNA antibody, Smith (SM) anti-
body, and ribonucleoprotein (RNP) antibody. Her
complement (CH50, C3, C4) levels were normal.
Serum rheumatoid factor and urine Histoplasma
capsulatum antigen were nondetectable. Blood cul-
tures for bacteria, mycobacteria and viruses
remained sterile for 21 days.
Histopathological examination of the pericar-
dial biopsy showed organizing hemorrhage and
prominent lymphocytic inﬁltration of the stroma.
(Figure 2a) Intranuclear and intracytoplasmic
inclusions within the reactive ﬁbroblasts showed
an ‘Owl’s eye’ pattern, characteristic of active
CMV infection [1–3] (Figure 2b). CMV-speciﬁc
IgG serum levels were 102 IU.
A 28-day treatment with ganciclovir (5mg/kg
body weight every 12 h) was commenced, and a
maintenance dose (5mg/kg body weight daily)
was given during the last 2 weeks. After disconti-
nuation of antiviral therapy, no clinical relapses
were noticed during the 12-month follow-up.
DIAGNOSIS
Cytomegaloviral pericarditis and cardiac tampo-
nade due to reactivation of latent infection.
DISCUSSION
1. Infections are the most frequent cause of peri-
cardial inﬂammation [4,5]. In some series, up to
40–86% of acute pericarditis in adults is
described as idiopathic [6,7]. Most, if not all,
cases of idiopathic pericarditis are thought to be
self-limiting, undiagnosed viral infections
caused by group B Coxsackie virus [8], group
A Coxsackie virus [9], echoviruses, adeno-
viruses, mumps virus, hepatitis B virus and
inﬂuenza virus [10,11]. In the post-antibiotic
era, bacterial infections of the pericardial sac
are rare, and during the last two decades, Strep-
tococcus pneumoniae has been replaced by Sta-
phylococcus aureus in this setting [12]. Unlike
pericarditis, however, cardiac tamponade is
commonly associated with non-infectious pro-
cesses [13].
2. In patients with acute viral pericarditis, fever
was seen in 59% andmost (>90%) patients with
purulent bacterial pericarditis were febrile [4,5].
Chest pain is often present and as many as 39–
76% of patients with subacute or chronic Myco-
bacterium tuberculosis infectionmay presentwith
dull, non-speciﬁc chest discomfort [14]. In con-
trast, our patient presented with dyspnea; fever
and chest pain were conspicuously absent.
3. The diagnostic yield of pericardial ﬂuid in
patients with uncomplicated acute pericarditis
is thought to be very low [15], and current
recommendations are to treat conservatively
unless the patient presents with hemodynamic
compromise. Diagnostic interventions may be
considered early in severely ill patients with
bacterial (Staphylococcus aureus, Gram-negative
bacilli), fungal (Histoplasma capsulatum) [16], or
parasitic (Toxoplasma gondii) infections [17]. A
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prospective evaluation of 256 immunocompe-
tent patients with acute pericarditis revealed
substantially low diagnostic yield (5%) by
both pericardial ﬂuid analysis and histological
examination of pericardial tissue. Albeit, in
patients with persistent pericardial effusions
for more than 3weeks, or clinically signiﬁcant
disease with hemodynamic compromise, diag-
nosis was made in 28% by pericardiocentesis
and more than half (54%) of pericardial tissue
biopsies were diagnostic [6]. Similarly, in this
case even the DNA-ampliﬁcation technique of
polymerase chain reaction failed, and diagnosis
was established by histological evidence of
intranuclear viral inclusions [2,18], suggesting
active CMV infection (Figure 2a,b). As healthy
individualsmay occasionally develop asympto-
matic, transient, low-grade CMV viremia, diag-
nosis of CMV pericarditis must be approached
with caution, andhistological evaluationmaybe
critical in determining an actual end-organ
infection due to CMV. The characteristic ‘Owl’s
eye’ basophilic intranuclear, intracytoplasmic
inclusions when present, are consistent with
CMV infection [1,2], although in cases charac-
teristic histological features may not be present
[2] and additional immunohistological and/or
DNA ampliﬁcation techniques may be needed.
Infections due to human herpes simplex virus,
human herpesvirus 6 and 7, and varicella zoster
virus may also present with intranuclear inclu-
sions, whereas infections due to CMV are char-
acteristically associated with intranuclear and
Figure 1 Computed tomography
scan of chest 5 days after the initial
pericardiocentesis, showing an in-
terval increase in the pericardial
fluid. The attenuation values of fluid
were 30–40 Houndsfield units,
which was consistent with hemor-
rhagic or proteinaceous effusion.
Figure 2 (a) The thickened and edematous pericardium
had a diffuse, predominantly lymphocytic infiltrate (H&E,
100). Perivascular cuffing by lymphocytes was present
(inset; H&E, 200). (b) Enlarged fibroblasts within the
pericardial stroma show nuclear and cytoplasmic inclu-
sions (arrow) pathogomonic of cytomegalovirus cytopathic
effect [2] (H&E, 400).
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intracytoplasmic basophilic viral inclusions
(Figure 2b) [2,3].
4. Patients with an underlying malignancy and
those with acquired immune deﬁcient syn-
drome (AIDS) are at higher risk of infections
due to opportunistic micro-organisms [19]. In
1–2% of patients with pulmonary M. tuberculo-
sis, infection may involve the adjoining pericar-
dium [14,20]. Prior to the AIDS epidemic, the
prevalence of tuberculous pericarditis was less
than 5% in Europe and North America [6,21]. In
contrast, pericarditis due to M. tuberculosis is a
major cause of heart disease inAfrica in patients
with AIDS [22]. Those undergoing chemo-
therapy for an underlyingmalignancy [23], reci-
pients of solid-organ transplantation [24], and
patients with AIDS [25] are also at risk for CMV
reactivation, which may, rarely, present as viral
pericarditis.
5. Purulent bacterial pericarditis due to S. aureus
and Gram-negative bacteria is most frequently
seen in chronically debilitated hospitalized
patients, and as with M. tuberculosis, if not
treated promptly it may be associated with
grave consequences [15]. CMV infections in
compromised patients are often serious and
pneumonitis may be associatedwith amortality
approaching 80–100% [26]. Early histological
identiﬁcation of pericardial infection and the
institution of appropriate therapy is critical in
patients with compromised immunity. In a ser-
ies of patient with probable CMV pericarditis
there was no evidence of relapse following clin-
ical resolution [27]. In our patient, 4-week anti-
viral therapy with ganciclovir was associated
with a durable response.
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